Union Therapeutics A/S
Records under this name other than the patents Union Therapeutics A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.
Back to Union Therapeutics A/S
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,758,553 | Antibacterial use of halogenated salicylanilides Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,384,096 | Substituted Azetidine Dihydrothienopyridines and Their Use as Phosphodiesterase Inhibitors Lapsed on the fee record Ended Jul 12, 2026 · High confidence | Lapsed on the fee record | Ended Jul 12, 2026 | High confidence |
| US 11,365,204 | Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors Lapsed on the fee record Ended Jun 21, 2026 · USPTO record | Lapsed on the fee record | Ended Jun 21, 2026 | USPTO record |
| US 11,331,289 | Antimicrobial composition Lapsed on the fee record Ended May 17, 2026 · USPTO record | Lapsed on the fee record | Ended May 17, 2026 | USPTO record |
| US 11,331,327 | Antibacterial use of halogenated salicylanilides Lapsed on the fee record Ended May 17, 2026 · USPTO record | Lapsed on the fee record | Ended May 17, 2026 | USPTO record |
| US 11,324,708 | Niclosamide formulations for treating disease Lapsed on the fee record Ended May 10, 2026 · USPTO record | Lapsed on the fee record | Ended May 10, 2026 | USPTO record |
| US 11,324,761 | Antibacterial use of halogenated salicylanilides Lapsed on the fee record Ended May 10, 2026 · USPTO record | Lapsed on the fee record | Ended May 10, 2026 | USPTO record |
| US 9,949,988 | Antibacterial use of halogenated salicylanilides Lapsed on the fee record Ended Apr 24, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 24, 2026 | USPTO record |
| US 11,285,164 | Antibacterial use of halogenated salicylanilides Lapsed on the fee record Ended Mar 29, 2026 · USPTO record | Lapsed on the fee record | Ended Mar 29, 2026 | USPTO record |
| US 11,213,533 | Combinations comprising dibromopropamidine or diminazene and a tetracycline anti-bacterial agent Lapsed on the fee record Ended Jan 4, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 4, 2026 | USPTO record |